Stryker (NYSE:SYK) Director Sells $178,926,000.00 in Stock

Stryker Corporation (NYSE:SYK) Director Ronda Stryker sold 550,000 shares of the company’s stock in a transaction dated Friday, November 6th. The shares were sold at an average price of $325.32, for a total transaction of $178,926,000.00. Following the transaction, the director directly owned 1,701,375 shares of the company’s stock, valued at $553,491,315. This represents a 24.43% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Stryker Price Performance

Shares of NYSE:SYK opened at $318.67 on Thursday. Stryker Corporation has a 1-year low of $267.00 and a 1-year high of $389.33. The firm has a market capitalization of $121.31 billion, a PE ratio of 33.94, a PEG ratio of 2.23 and a beta of 0.78. The business’s 50 day moving average is $292.27 and its 200-day moving average is $323.05. The company has a current ratio of 2.18, a quick ratio of 1.30 and a debt-to-equity ratio of 0.60.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, October 29th. The medical technology company reported $3.52 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.55 by ($0.03). The firm had revenue of $6.52 billion for the quarter, compared to the consensus estimate of $6.62 billion. Stryker had a net margin of 13.78% and a return on equity of 23.74%. The business’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.19 earnings per share. Sell-side analysts predict that Stryker Corporation will post 14.85 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have recently commented on SYK shares. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Stryker in a report on Thursday, October 29th. Johnson Rice cut shares of Stryker to a “hold” rating in a research note on Friday, October 30th. Sanford C. Bernstein reissued a “market perform” rating on shares of Stryker in a research report on Wednesday, October 7th. Evercore increased their price target on shares of Stryker from $335.00 to $355.00 in a research report on Wednesday, October 28th. Finally, Citizens Jmp cut their price target on shares of Stryker from $400.00 to $390.00 and set a “market outperform” rating for the company in a research note on Friday, October 30th. Twenty-one investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, Stryker currently has an average rating of “Moderate Buy” and an average price target of $342.19.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Community Bank & Trust Waco Texas increased its position in shares of Stryker by 2.3% during the 2nd quarter. Community Bank & Trust Waco Texas now owns 1,395 shares of the medical technology company’s stock worth $439,000 after purchasing an additional 31 shares in the last quarter. Cornerstone Financial Management LLC boosted its position in Stryker by 66.0% in the second quarter. Cornerstone Financial Management LLC now owns 78 shares of the medical technology company’s stock valued at $25,000 after buying an additional 31 shares in the last quarter. Nicholson Wealth Management Group LLC grew its stake in Stryker by 0.6% during the third quarter. Nicholson Wealth Management Group LLC now owns 5,184 shares of the medical technology company’s stock worth $1,428,000 after buying an additional 32 shares during the last quarter. NWF Advisory Services Inc. grew its stake in Stryker by 2.3% during the second quarter. NWF Advisory Services Inc. now owns 1,472 shares of the medical technology company’s stock worth $463,000 after buying an additional 33 shares during the last quarter. Finally, Private Harbour Investment Management & Counsel LLC increased its holdings in shares of Stryker by 0.9% during the second quarter. Private Harbour Investment Management & Counsel LLC now owns 3,927 shares of the medical technology company’s stock worth $1,236,000 after buying an additional 34 shares in the last quarter. 77.09% of the stock is owned by institutional investors.

Stryker Company Profile

Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings. The company’s products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.